Mimedx (MDXG) EBIT Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
Mimedx (MDXG) EBIT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn | 244.00 |
| 10 | Mimedx | 676.17 Mn | 540.33 Mn | 44.38 Mn | -4,203.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,203.00 |
| Mar 31, 2026 | -2,673.00 |
| Dec 31, 2025 | 264.00 |
| Sep 30, 2025 | 3,001.00 |
| Jun 30, 2025 | 2,695.00 |
| Mar 31, 2025 | 2,515.00 |
| Dec 31, 2024 | 937.00 |
| Sep 30, 2024 | 1,498.00 |
| Jun 30, 2024 | 2,749.00 |
| Mar 31, 2024 | 2,701.00 |
| Dec 31, 2023 | 4,131.00 |
| Sep 30, 2023 | 2,871.00 |
| Jun 30, 2023 | 2,425.00 |
| Mar 31, 2023 | 2,179.00 |
| Dec 31, 2022 | 2,159.00 |
| Sep 30, 2022 | -2,647.00 |
| Jun 30, 2022 | 1,091.00 |
| Mar 31, 2022 | 436.00 |
| Dec 31, 2021 | 1,219.00 |
| Sep 30, 2021 | -213.00 |